Animal health company Elanco (NYSE:ELAN) reported Q1 CY2025 results , but sales were flat year on year at $1.19 billion. The company’s full-year revenue guidance of $4.55 billion at the midpoint came ...
Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 44th Annual J.P. Morgan Healthcare Conference on ...
Animal health company Elanco (NYSE:ELAN) reported in Q2 CY2025, with sales up 4.8% year on year to $1.24 billion. Guidance for next quarter’s revenue was better than expected at $1.1 billion at the ...
For most of its six decades, Elanco Animal Health operated below the radar, serving as a small division of drugmaker Eli Lilly and Co., with operations spread across rural Hancock County, quietly ...
BiomEdit intends to discover and develop animal health products that leverage microbiome science to improve animal health, animal protein production, and livestock disease monitoring Microbiome ...
INDIANAPOLIS, Dec. 9, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) hosts its first Investor Day in five years this morning, marking a pivotal moment as the company further ...
Elanco’s new headquarters on the west edge of downtown is scheduled to open early next year. (IBJ photo/Mickey Shuey) Ancora Holdings Inc. might be the scrappiest investment firm you’ve never heard of ...
In a recent move demonstrating confidence in Elanco Animal Health Inc (NYSE:ELAN), President, CEO, and Director Jeffrey N. Simmons purchased 100,000 shares of the company's common stock. The ...
Elanco Animal Health Inc (NYSE:ELAN) director Michael J. Harrington has recently increased his stake in the company, according to the latest filings with the Securities and Exchange Commission. On ...
Aaron Schacht transitions to lead the carve-out of Elanco’s microbiome R&D platform, aiming to create a privately funded, independent, biopharmaceutical company focused on microbiome-derived solutions ...
Elanco Animal Health Inc. plans to eliminate roughly 380 jobs worldwide, including 20% of its senior management, in a plan aimed at simplifying the company's structure and enabling future and planned ...